Post by VentureCapital Magazin

Tubulis GmbH: Developing a new generation of ADC therapies 🧬 Tubulis wants to improve the efficacy of cancer therapies by using antibody drug conjugates (ADCs). Three pipeline products are currently in clinical #development! 💬 ‘We are where we are today thanks in part to the commitment of German and European investors,’ says Dr Dominik Schumacher (CEO, #Tubulis)! Find the full case study here: https://lnkd.in/dBg3nx6E #bio #cancer #lifescience #impactlifesciences #vc #vcmagazin IZB - Innovation and Start-up Center Biotechnology Karin Hofelich #munich Trophic Communications #tech #health #innovation #investing #ADC #medicine Ludwig-Maximilians-Universität München Helmholtz Munich #casestudy #startup